NasdaqCM - Nasdaq Real Time Price USD

Firefly Neuroscience, Inc. (AIFF)

0.9102 +0.0001 (+0.01%)

At close: November 6 at 4:00:00 PM EST

0.9100 -0.0001 (-0.01%)

Overnight: 11:47:04 PM EST

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Firefly Neuroscience (NASDAQ: AIFF) Strengthens Non-Invasive Brain-Computer Interface Growth Strategy with Commercially Available Versus Platform

GlobeNewswire 12d ago

AIFF
0.00%
Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD

GlobeNewswire 1mo ago

AIFF
0.00%
Firefly Neuroscience’s Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial’s AI-Native Operating System for Brain Medicine

GlobeNewswire 1mo ago

AIFF
0.00%
Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes

GlobeNewswire 3mo ago

AIFF
0.00%
Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides

GlobeNewswire 3mo ago

AIFF
0.00%
Firefly’s AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD

GlobeNewswire 5mo ago

AIFF
0.00%
With Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World’s First Known 200,000+ Standardized EEG/ERP Depository

GlobeNewswire 6mo ago

AIFF
0.00%
NVDA
The Small Cap Showcase Highlights 8 Public Companies at Their Investor Conference Today

ACCESS Newswire 1mo ago

CRDOF

DCOY

ACCS
BC-Most Active Stocks

Associated Press Finance 7mo ago

^IXIC

LNAI

NVDA
Firefly Confirms Public-Private Partnership with the Department of War

GlobeNewswire 7mo ago

AIFF
0.00%
BC-Most Active Stocks

Associated Press Finance 7mo ago

ISPC

^IXIC

BIAF
Firefly Announces Discovery of New Brain Wave Biomarkers For Differential Diagnosis of ADHD

GlobeNewswire 7mo ago

AIFF
0.00%

Performance Overview

Return	AIFF	S&P 500 (^GSPC)
YTD	+3.43%	+7.76%
1-Year	-42.75%	+9.77%
3-Year	-78.01%	+68.96%

U.S. markets open in 4h 18m

Firefly Neuroscience, Inc. (AIFF)

Firefly Neuroscience (NASDAQ: AIFF) Strengthens Non-Invasive Brain-Computer Interface Growth Strategy with Commercially Available Versus Platform

Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD

Firefly Neuroscience’s Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial’s AI-Native Operating System for Brain Medicine

Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes

Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides

Firefly’s AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD

With Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World’s First Known 200,000+ Standardized EEG/ERP Depository

The Small Cap Showcase Highlights 8 Public Companies at Their Investor Conference Today

BC-Most Active Stocks

Firefly Confirms Public-Private Partnership with the Department of War

BC-Most Active Stocks

Firefly Announces Discovery of New Brain Wave Biomarkers For Differential Diagnosis of ADHD